<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Original Article: Maintenance of an Asthma Intervention Post-Trial

Use of a Patient-Activated Reliever-Triggered Inhaled Corticosteroid (PARTICS) Strategy in Black and Latinx Patients.

minute read

by Liz Campbell | July 10, 2025
Inhaler in foreground and blister pack of pills in background

"Maintenance of an Asthma Intervention Post-Trial: Use of a Patient-Activated Reliever-Triggered Inhaled Corticosteroid (PARTICS) Strategy in Black and Latinx Patients"

JABFM
March 2025

Elizabeth Staton, MS, Senior Instructor for the University of Colorado Department of Family Medicine (CU DFM), is a contributing author of the recent JABFM article "Maintenance of an Asthma Intervention Post-Trial: Use of a Patient-Activated Reliever-Triggered Inhaled Corticosteroid (PARTICS) Strategy in Black and Latinx Patients." She also played a key role in securing funding for the research that went into this publication. 

This paper is one of many published by the PREPARE study, a large comparative effectiveness study funded by PCORI to study a new way to reduce asthma attacks among Hispanic/Latino and Black/African American people with moderate to severe asthma: using an inhaled corticosteroid at the same time as people use a reliever inhaler. This approach is called Patient-Activated Reliever-Triggered Inhaled Corticosteroid (PARTICS). Overall, the study found that PARTICS led to a lower rate of severe asthma exacerbations, better asthma control and quality of life, and fewer days missed from work, school, and usual activities. This particular paper looked at whether study participants continued using the PARTICS method of treating their asthma after the study ended. The study found that more than 2 years after the study, continued PARTICS use was common and was perceived as helpful for asthma.

When asked about the publication, Professor Staton shared: "The PREPARE study was exciting for me because it was the largest (at the time) grant that I had a major hand in securing: $14 million. I worked closely with the PI and the writing team on their second submission to PCORI. It was a lot of work, but we were successful. It’s great to see the papers roll out after a study. My contributions were part of my time I spend supporting the AAFP National Research Network."

Other members of the CU DFM associated with this publication: Wilson Pace, MD (emeritus professor). 

Elizabeth Staton

 

Comments